RxDoctor Payments Data

Chassity Jones, APRN

Family · Madison, TNNPI 1952889859

Payments from drug & device makers

$9,472in general payments, 2019–2025

Across 356 payments — averaging $26.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$779
  • Daiichi Sankyo Inc.$722
  • Novartis$635
  • Johnson & Johnson$614
  • Merck$531
  • Seagen Inc.$356
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$9,02895%
  • Education$4445%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)33$779
Daiichi Sankyo Inc.27$722
Novartis24$635
Johnson & Johnson(2 entities)21$614
Merck19$531
Seagen Inc.6$356
Incyte Corporation18$334
Regeneron Healthcare Solutions, Inc.13$324
Eisai Inc.13$320
Gilead(2 entities)6$290
Jazz Pharmaceuticals Inc.8$285
Takeda Pharmaceuticals U.S.A., Inc.7$271
Sanofi9$263
E.r. Squibb & Sons, L.L.C.6$199
AbbVie7$166
Pfizer9$164
Bristol Myers Squibb6$152
Bayer8$148
EMD Serono, Inc.7$146
Tersera Therapeutics LLC6$145
Lilly USA, LLC6$139
Genentech USA, Inc.7$137
CTI Biopharma Corp.2$134
Ipsen Biopharmaceuticals, Inc4$124
Genmab U.S., Inc.5$121
AVEO Pharmaceuticals, Inc.3$121
Dendreon Pharmaceuticals LLC3$120
Boehringer Ingelheim4$107
Servier Pharmaceuticals LLC1$103
Exelixis Inc.4$94
Puma Biotechnology, Inc.5$89
Pharmaessentia USA Corporation4$85
Astellas Pharma US Inc1$80
Sobi, Inc4$77
Pharmacosmos Therapeutics Inc.4$70
Rigel Pharmaceuticals, Inc.3$68
Taiho Oncology, Inc.3$66
Mirati Therapeutics, Inc.3$63
Legend Biotech USA Inc.2$58
Sumitomo Pharma America, Inc.3$56
Beigene USA, Inc.3$53
Agios Pharmaceuticals, Inc.3$49
Deciphera Pharmaceuticals Inc.2$49
Blueprint Medicines Corporation1$44
Caris MPI, Inc.1$42
ADC Therapeutics America, Inc.2$41
Karyopharm Therapeutics Inc.2$39
Amgen2$37
Cycle Pharmaceuticals Inc2$35
Recordati_rare_diseases_inc.1$32
Kyowa Kirin, Inc.1$30
GSK1$28
Verity Pharmaceuticals Inc.1$28
Tempus AI, Inc1$28
Alnylam Pharmaceuticals Inc.1$25
Stemline Therapeutics Inc.1$25
Corcept Therapeutics1$23
Progenics Pharmaceuticals, Inc.1$21
Syndax Pharmaceuticals, Inc.1$20
Beone Medicines USA, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,472 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$35,354
Medicare patients
26
Services billed
2,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyurea28$1,141
Anastrozole27$646
Tamoxifen Citrate20$473
Methylprednisolone14$64
Triamcinolone Acetonide11$42

Paid to pharmacies, not to this prescriber.

Other family in Madison

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →